Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 090237
Company: SANDOZ

Products on ANDA 090237

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL	5MG	TABLET;ORAL	Discontinued	None	No	No
OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL	20MG	TABLET;ORAL	Discontinued	None	No	No
OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL	40MG	TABLET;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 090237

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
04/13/2020	ORIG-1	Approval				Label is not available on this site.